Furthermore, studies have demonstrated that diabetes-induced activation of GSK-3β and impairment of RISK play critical roles in diabetes-induced myocardial oxidative damage and remodeling [43, 63]; other studies also reported that the activity of GSK-3β is twice in diabetic patients compared to that of nondiabetic patients [84]. Here, GSK3B is linked to diabetes mellitus.